Sir Mortimer B. Davis - Jewish General Hospital
Clinical trials sponsored by Sir Mortimer B. Davis - Jewish General Hospital, explained in plain language.
-
New combo therapy aims to delay prostate cancer progression
Disease control OngoingThis phase II trial tests whether adding precise radiation (SBRT) to the hormone therapy darolutamide can delay cancer progression in men with castration-resistant prostate cancer that has only a few new spots of growth. The study involves 66 participants and measures how long it…
Phase: PHASE2 • Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New rectal cancer device tested in elderly patients
Disease control TerminatedThis pilot study tests a new rectal applicator for delivering radiation therapy to elderly patients with inoperable rectal cancer. The treatment combines external beam radiation with three sessions of internal radiation (brachytherapy) using the new device. The study aims to see …
Phase: NA • Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Babywearing may boost mother-infant bonding in anxious moms
Symptom relief ENROLLING_BY_INVITATIONThis pilot study tests whether using a soft baby carrier for extra physical contact helps mothers with prenatal anxiety or depression feel more connected to their baby. Forty moms in Montreal will either use the carrier or be on a waitlist. Researchers will measure bonding, brain…
Phase: NA • Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC